Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting.

Tiernan, JP, Perry, SL, Verghese, ET et al. (4 more authors) (2013) Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting. British Journal of Cancer, 108 (3). 662 - 667. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Tiernan, JP
  • Perry, SL
  • Verghese, ET
  • West, NP
  • Yeluri, S
  • Jayne, DG
  • Hughes, TA
Copyright, Publisher and Additional Information: (c) 2013 Cancer Research UK. All rights reserved. This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
Keywords: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Carcinoembryonic Antigen; Case-Control Studies; Colon; Colorectal Neoplasms; Female; Folate Receptor 1; Follow-Up Studies; Glycoproteins; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; ROC Curve; Receptor, Epidermal Growth Factor; Rectum; Tumor Markers, Biological
Dates:
  • Published: February 2013
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Molecular Gastroenterology (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Biomed & Clin Sciences (LIBACS) (Leeds) > Trans Anaesthetics & Surgical Sciences (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 10 Nov 2015 14:44
Last Modified: 10 Nov 2015 14:44
Published Version: http://dx.doi.org/10.1038/bjc.2012.605
Status: Published
Publisher: Cancer Research UK
Identification Number: https://doi.org/10.1038/bjc.2012.605
Related URLs:

Share / Export

Statistics